Richard Sainson, PhD @rcasainson of @KymabLtd explains KY1044, targets ICOS increasing cytotoxic to regulatory T cells ratio: what mechanism of action is the most relevant for targeting ICOS?
What Mechanism of Action is the Most Relevant for Targeting ICOS? @rcasainson @KymabLtd
